These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23146437)

  • 1. Simultaneous inhibition of metastasis and growth of breast cancer by co-delivery of twist shRNA and paclitaxel using pluronic P85-PEI/TPGS complex nanoparticles.
    Shen J; Sun H; Xu P; Yin Q; Zhang Z; Wang S; Yu H; Li Y
    Biomaterials; 2013 Feb; 34(5):1581-90. PubMed ID: 23146437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-delivery of paclitaxel and survivin shRNA by pluronic P85-PEI/TPGS complex nanoparticles to overcome drug resistance in lung cancer.
    Shen J; Yin Q; Chen L; Zhang Z; Li Y
    Biomaterials; 2012 Nov; 33(33):8613-24. PubMed ID: 22910221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. iRGD conjugated TPGS mediates codelivery of paclitaxel and survivin shRNA for the reversal of lung cancer resistance.
    Shen J; Meng Q; Sui H; Yin Q; Zhang Z; Yu H; Li Y
    Mol Pharm; 2014 Aug; 11(8):2579-91. PubMed ID: 24236909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled preparation and antitumor efficacy of vitamin E TPGS-functionalized PLGA nanoparticles for delivery of paclitaxel.
    Wang G; Yu B; Wu Y; Huang B; Yuan Y; Liu CS
    Int J Pharm; 2013 Mar; 446(1-2):24-33. PubMed ID: 23402977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-delivery of hydrophobic paclitaxel and hydrophilic AURKA specific siRNA by redox-sensitive micelles for effective treatment of breast cancer.
    Yin T; Wang L; Yin L; Zhou J; Huo M
    Biomaterials; 2015 Aug; 61():10-25. PubMed ID: 25996409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of metastasis and growth of breast cancer by pH-sensitive poly (β-amino ester) nanoparticles co-delivering two siRNA and paclitaxel.
    Tang S; Yin Q; Su J; Sun H; Meng Q; Chen Y; Chen L; Huang Y; Gu W; Xu M; Yu H; Zhang Z; Li Y
    Biomaterials; 2015 Apr; 48():1-15. PubMed ID: 25701027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Surfactant on Paclitaxel Nanocrystals: An In Vitro and In Vivo Study.
    Liu H; Ma Y; Liu D; Fallon JK; Liu F
    J Biomed Nanotechnol; 2016 Jan; 12(1):147-53. PubMed ID: 27301180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy.
    Xu C; Liu W; Hu Y; Li W; Di W
    Theranostics; 2020; 10(7):3325-3339. PubMed ID: 32194871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatment.
    Assanhou AG; Li W; Zhang L; Xue L; Kong L; Sun H; Mo R; Zhang C
    Biomaterials; 2015 Dec; 73():284-95. PubMed ID: 26426537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor environment differentiated "nanodepot" programmed for site-specific drug shuttling and combinative therapy on metastatic cancer.
    Dong Q; Zhang H; Han Y; Djamila A; Cheng H; Tang Z; Zhou J; Ding Y
    J Control Release; 2018 Aug; 283():59-75. PubMed ID: 29803613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrogen-bonded and reduction-responsive micelles loading atorvastatin for therapy of breast cancer metastasis.
    Xu P; Yu H; Zhang Z; Meng Q; Sun H; Chen X; Yin Q; Li Y
    Biomaterials; 2014 Aug; 35(26):7574-87. PubMed ID: 24899527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic inhibition of breast cancer by co-delivery of VEGF siRNA and paclitaxel via vapreotide-modified core-shell nanoparticles.
    Feng Q; Yu MZ; Wang JC; Hou WJ; Gao LY; Ma XF; Pei XW; Niu YJ; Liu XY; Qiu C; Pang WH; Du LL; Zhang Q
    Biomaterials; 2014 Jun; 35(18):5028-38. PubMed ID: 24680191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of PEGylated paclitaxel nanocrystals on breast cancer and its lung metastasis.
    Zhang H; Hu H; Zhang H; Dai W; Wang X; Wang X; Zhang Q
    Nanoscale; 2015 Jun; 7(24):10790-800. PubMed ID: 26038337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyethyleneimine grafted with pluronic P85 enhances Ku86 antisense delivery and the ionizing radiation treatment efficacy in vivo.
    Belenkov AI; Alakhov VY; Kabanov AV; Vinogradov SV; Panasci LC; Monia BP; Chow TY
    Gene Ther; 2004 Nov; 11(22):1665-72. PubMed ID: 15470482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-tocopheryl polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles for reversal of multidrug resistance in vitro.
    Wang Y; Guo M; Lu Y; Ding LY; Ron WT; Liu YQ; Song FF; Yu SQ
    Nanotechnology; 2012 Dec; 23(49):495103. PubMed ID: 23149859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic inhibition of breast cancer metastasis by silibinin-loaded lipid nanoparticles containing TPGS.
    Xu P; Yin Q; Shen J; Chen L; Yu H; Zhang Z; Li Y
    Int J Pharm; 2013 Sep; 454(1):21-30. PubMed ID: 23830941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer.
    Lv S; Tang Z; Li M; Lin J; Song W; Liu H; Huang Y; Zhang Y; Chen X
    Biomaterials; 2014 Jul; 35(23):6118-29. PubMed ID: 24794923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shrapnel nanoparticles loading docetaxel inhibit metastasis and growth of breast cancer.
    Xu P; Meng Q; Sun H; Yin Q; Yu H; Zhang Z; Cao M; Zhang Y; Li Y
    Biomaterials; 2015 Sep; 64():10-20. PubMed ID: 26106797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-delivery of TRAIL gene enhances the anti-glioblastoma effect of paclitaxel in vitro and in vivo.
    Zhan C; Wei X; Qian J; Feng L; Zhu J; Lu W
    J Control Release; 2012 Jun; 160(3):630-6. PubMed ID: 22410115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual pH-sensitive micelles with charge-switch for controlling cellular uptake and drug release to treat metastatic breast cancer.
    Tang S; Meng Q; Sun H; Su J; Yin Q; Zhang Z; Yu H; Chen L; Gu W; Li Y
    Biomaterials; 2017 Jan; 114():44-53. PubMed ID: 27842234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.